Archive for the 'Medicaid' Category

The Morning After

By Kurt A. Proctor, Ph.D., RPh, NCPA Senior Vice President, Strategic Initiatives

After a great NCPA Annual Meeting in Austin, we weren’t done. On Wednesday, October 22nd we kept the momentum going with a day-long “Networking for High Performance Pharmacies” program for a standing room only crowd of 140 industry leaders. This provocative program afforded like-minded pharmacists not only the opportunity to get to know each other but to engage with public and private payers to hear about their plans for pay-for-performance and quality related network inclusion criteria.

Continue reading ‘The Morning After’

Congressional Attention Focused on Independent Community Pharmacy and Patient Access to Care

By Michael Rule, Manager of Public Affairs and Grassroots Advocacy

NCPA’s 45th annual Legislative Conference wrapped up this week, and the timing could not have been more appropriate for independent community pharmacy. It was whirlwind week of legislative activity, to recap:

Continue reading ‘Congressional Attention Focused on Independent Community Pharmacy and Patient Access to Care’

Pharmacies Can Help Alleviate Drug Shortages, but Reimbursement Must Keep Up with Costs

By Kevin Schweers

With prescription drug shortages and pharmacy compounding hot topics, NCPA recently weighed in with Food and Drug Administration (FDA) officials on both fronts, in hopes of preserving patient access to essential medications from their independent community pharmacist. Continue reading ‘Pharmacies Can Help Alleviate Drug Shortages, but Reimbursement Must Keep Up with Costs’

NCPA Renews Concerns over Medicaid Generic Drug Reimbursement Changes

By Kevin Schweers

The U.S. Centers for Medicare & Medicaid Services (CMS) has published the 11th version of its draft federal upper limits (FULs) for Medicaid generic drug reimbursement, but the results are getting worse, not better, than preceding lists in terms of assuring continued patient access to prescription drugs and pharmacy services.

Continue reading ‘NCPA Renews Concerns over Medicaid Generic Drug Reimbursement Changes’

NCPA Urges Medicaid Officials to Fix Flawed Generic Drug Reimbursement Caps

By Kevin Schweers

The most recent batch proposed Medicaid caps on generic drug reimbursement—or federal upper limits (FULs)—would be “economically devastating” for independent community pharmacies, NCPA told federal officials in a new letter. Such cuts could endanger pharmacy access for Medicaid recipients as community pharmacies may be forced to drop out of the program or, in some cases, to close altogether.

Continue reading ‘NCPA Urges Medicaid Officials to Fix Flawed Generic Drug Reimbursement Caps’

NCPA Legislative Conference: Pharmacists Talk Medicare, Medicaid, Jobs

Between the Express Scripts-Medco merger, pharmacy crime, mail order in Tricare, and potential track and trace requirements in PDUFA, the 2012 NCPA Legislative Conference couldn’t be happening at a more relevant time, NCPA President Lonny Wilson, PD noted during the May 7th opening session.

Continue reading ‘NCPA Legislative Conference: Pharmacists Talk Medicare, Medicaid, Jobs’

New Limits on Medicaid Generic Drug Reimbursement Proposed; Same Inadequate Result

By Kevin Schweers

Earlier this month the Centers for Medicare & Medicaid Services issued its fifth set of proposed Medicaid federal upper limits (FULs) for generic drug reimbursement, but it’s no better than its four predecessors for patients and their community pharmacists, NCPA recently wrote to the agency.

Continue reading ‘New Limits on Medicaid Generic Drug Reimbursement Proposed; Same Inadequate Result’


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 466 other followers